Report highlights big gaps in cancer outcomes based on race
U.S. cancer death rates are continuing to drop, falling by 33% between 1991 and 2020.
May 15, 2024
0
29
Cardiovascular Diseases: News and Research on Hemostatic Disorders
MeSH tree: C14.907.454
Study shows derivatives of thalidomide compound drive resistant cancer cells to their deaths
A study by Goethe University Frankfurt points to the possibility that thalidomide derivatives are potentially suitable for treating cancer. Thalidomide was marketed in the 1950s as a sleeping pill. It later gained sad notoriety ...
May 13, 2024
0
70
Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study finds
Patients in remission after battling a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.
May 2, 2024
0
49
Biomarkers identified for successful treatment of bone marrow tumors
CAR T cell therapy has proven effective in treating various hematological cancers. However, not all patients respond equally well to treatment. In a clinical study, researchers from the University of Leipzig Medical Center ...
Apr 26, 2024
0
54
Stem cell transplants and survival rates on the rise across all racial and ethnic groups
The volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster among African Americans and Hispanics compared with non-Hispanic white individuals, mirroring changes in population growth ...
Apr 25, 2024
0
30
Study reviews the role of a ribonucleic acid 'MALAT1' in hematological malignancies
Long non-coding ribonucleic acids (lncRNAs), despite not coding for any protein, can play a significant role in cancer formation, progression, and treatment outcomes. One such lncRNA of interest is MALAT1, abbreviated for ...
Apr 24, 2024
0
43
Study points to racial and social barriers that block treatment for multiple myeloma
A UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplant treatment to halt the progression of multiple myeloma.
Apr 23, 2024
0
34
AI tool predicts responses to cancer therapy using information from each cell of the tumor
With more than 200 types of cancer and every cancer individually unique, ongoing efforts to develop precision oncology treatments remain daunting. Most of the focus has been on developing genetic sequencing assays or analyses ...
Apr 18, 2024
0
74
New research identifies promising drug combination for multiple myeloma treatment
New research from the Royal College of Surgeons in Ireland has found that venetoclax, a medication currently approved for leukemia, provides benefits for patients with multiple myeloma when used in combination with another ...
Mar 25, 2024
0
39
Advances in multiple myeloma treatment
March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often occurs in people over age 45. It's the second-most common blood cancer and the most common blood cancer in Black people.
Mar 15, 2024
0
58
